A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer

Vascular endothelial growth factor (VEGF) is expressed in human bladder tumors. A phase II study was conducted to assess the VEGF inhibitor pazopanib in patients with metastatic, urothelial carcinoma. Nineteen patients with one prior systemic therapy were enrolled. No objective responses were observ...

詳細記述

保存先:
書誌詳細
主要な著者: Pili, Roberto, Qin, Rui, Flynn, P.J., Picus, Joel, Millward, Michael, Ho, Wing Ming, Pitot, Henry, Tan, Winston, Miles, Kiersten M., Erlichman, Charles, Vaishampayan, Ulka
フォーマット: Artigo
言語:Inglês
出版事項: 2013
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4102930/
https://ncbi.nlm.nih.gov/pubmed/23891158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2013.05.005
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料